Global Veterinary Biological Vaccines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Veterinary Biological Vaccines market size is predicted to grow from US$ 5606 million in 2025 to US$ 8006 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly Đ‚6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 551%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Biological Vaccines Industry Forecast” looks at past sales and reviews total world Veterinary Biological Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Biological Vaccines sales for 2025 through 2031. With Veterinary Biological Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Biological Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Biological Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Biological Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Biological Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Biological Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Biological Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biological Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Veterinary Biological Vaccines market?
What factors are driving Veterinary Biological Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Biological Vaccines market opportunities vary by end market size?
How does Veterinary Biological Vaccines break out by Type, by Application?
The global Veterinary Biological Vaccines market size is predicted to grow from US$ 5606 million in 2025 to US$ 8006 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly Đ‚6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 551%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Biological Vaccines Industry Forecast” looks at past sales and reviews total world Veterinary Biological Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Biological Vaccines sales for 2025 through 2031. With Veterinary Biological Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Biological Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Biological Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Biological Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Biological Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Biological Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Biological Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biological Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
- Livestock
- Swine
- Chicken
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- Ringpu Biology
- Jinyu Bio-technology
- Jinhe Biotechnology
- China Animal Husbandry Industry
- Wuhan Keqian Biology
- Pulike Biological Engineering
- Chengdu Kanghua Biological Products
What is the 10-year outlook for the global Veterinary Biological Vaccines market?
What factors are driving Veterinary Biological Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Biological Vaccines market opportunities vary by end market size?
How does Veterinary Biological Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Biological Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Biological Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Biological Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Biological Vaccines Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Others
2.3 Veterinary Biological Vaccines Sales by Type
2.3.1 Global Veterinary Biological Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Biological Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Biological Vaccines Sale Price by Type (2020-2025)
2.4 Veterinary Biological Vaccines Segment by Application
2.4.1 Livestock
2.4.2 Swine
2.4.3 Chicken
2.4.4 Others
2.5 Veterinary Biological Vaccines Sales by Application
2.5.1 Global Veterinary Biological Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Biological Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Biological Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Biological Vaccines Breakdown Data by Company
3.1.1 Global Veterinary Biological Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Biological Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Biological Vaccines Revenue by Company (2020-2025)
3.2.2 Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Biological Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Biological Vaccines Product Location Distribution
3.4.2 Players Veterinary Biological Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY BIOLOGICAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Biological Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Biological Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Biological Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Biological Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Biological Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Biological Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Biological Vaccines Sales Growth
4.4 APAC Veterinary Biological Vaccines Sales Growth
4.5 Europe Veterinary Biological Vaccines Sales Growth
4.6 Middle East & Africa Veterinary Biological Vaccines Sales Growth
5 AMERICAS
5.1 Americas Veterinary Biological Vaccines Sales by Country
5.1.1 Americas Veterinary Biological Vaccines Sales by Country (2020-2025)
5.1.2 Americas Veterinary Biological Vaccines Revenue by Country (2020-2025)
5.2 Americas Veterinary Biological Vaccines Sales by Type (2020-2025)
5.3 Americas Veterinary Biological Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Biological Vaccines Sales by Region
6.1.1 APAC Veterinary Biological Vaccines Sales by Region (2020-2025)
6.1.2 APAC Veterinary Biological Vaccines Revenue by Region (2020-2025)
6.2 APAC Veterinary Biological Vaccines Sales by Type (2020-2025)
6.3 APAC Veterinary Biological Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Biological Vaccines by Country
7.1.1 Europe Veterinary Biological Vaccines Sales by Country (2020-2025)
7.1.2 Europe Veterinary Biological Vaccines Revenue by Country (2020-2025)
7.2 Europe Veterinary Biological Vaccines Sales by Type (2020-2025)
7.3 Europe Veterinary Biological Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Biological Vaccines by Country
8.1.1 Middle East & Africa Veterinary Biological Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Biological Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Biological Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines
10.3 Manufacturing Process Analysis of Veterinary Biological Vaccines
10.4 Industry Chain Structure of Veterinary Biological Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Biological Vaccines Distributors
11.3 Veterinary Biological Vaccines Customer
12 WORLD FORECAST REVIEW FOR VETERINARY BIOLOGICAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Veterinary Biological Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary Biological Vaccines Forecast by Region (2026-2031)
12.1.2 Global Veterinary Biological Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Biological Vaccines Forecast by Type (2026-2031)
12.7 Global Veterinary Biological Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Biological Vaccines Product Portfolios and Specifications
13.1.3 Merck Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Biological Vaccines Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Biological Vaccines Product Portfolios and Specifications
13.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Biological Vaccines Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Biological Vaccines Product Portfolios and Specifications
13.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Yebio
13.7.1 Yebio Company Information
13.7.2 Yebio Veterinary Biological Vaccines Product Portfolios and Specifications
13.7.3 Yebio Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Yebio Main Business Overview
13.7.5 Yebio Latest Developments
13.8 DHN
13.8.1 DHN Company Information
13.8.2 DHN Veterinary Biological Vaccines Product Portfolios and Specifications
13.8.3 DHN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 DHN Main Business Overview
13.8.5 DHN Latest Developments
13.9 WINSUN
13.9.1 WINSUN Company Information
13.9.2 WINSUN Veterinary Biological Vaccines Product Portfolios and Specifications
13.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 WINSUN Main Business Overview
13.9.5 WINSUN Latest Developments
13.10 Elanco
13.10.1 Elanco Company Information
13.10.2 Elanco Veterinary Biological Vaccines Product Portfolios and Specifications
13.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Elanco Main Business Overview
13.10.5 Elanco Latest Developments
13.11 Virbac
13.11.1 Virbac Company Information
13.11.2 Virbac Veterinary Biological Vaccines Product Portfolios and Specifications
13.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Virbac Main Business Overview
13.11.5 Virbac Latest Developments
13.12 CAVAC
13.12.1 CAVAC Company Information
13.12.2 CAVAC Veterinary Biological Vaccines Product Portfolios and Specifications
13.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CAVAC Main Business Overview
13.12.5 CAVAC Latest Developments
13.13 Kyoto Biken Laboratories
13.13.1 Kyoto Biken Laboratories Company Information
13.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolios and Specifications
13.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Kyoto Biken Laboratories Main Business Overview
13.13.5 Kyoto Biken Laboratories Latest Developments
13.14 FATRO
13.14.1 FATRO Company Information
13.14.2 FATRO Veterinary Biological Vaccines Product Portfolios and Specifications
13.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 FATRO Main Business Overview
13.14.5 FATRO Latest Developments
13.15 Vaksindo
13.15.1 Vaksindo Company Information
13.15.2 Vaksindo Veterinary Biological Vaccines Product Portfolios and Specifications
13.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Vaksindo Main Business Overview
13.15.5 Vaksindo Latest Developments
13.16 Bio-Labs
13.16.1 Bio-Labs Company Information
13.16.2 Bio-Labs Veterinary Biological Vaccines Product Portfolios and Specifications
13.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Bio-Labs Main Business Overview
13.16.5 Bio-Labs Latest Developments
13.17 Avimex Animal Health
13.17.1 Avimex Animal Health Company Information
13.17.2 Avimex Animal Health Veterinary Biological Vaccines Product Portfolios and Specifications
13.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Avimex Animal Health Main Business Overview
13.17.5 Avimex Animal Health Latest Developments
13.18 MEVAC
13.18.1 MEVAC Company Information
13.18.2 MEVAC Veterinary Biological Vaccines Product Portfolios and Specifications
13.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 MEVAC Main Business Overview
13.18.5 MEVAC Latest Developments
13.19 Biovac
13.19.1 Biovac Company Information
13.19.2 Biovac Veterinary Biological Vaccines Product Portfolios and Specifications
13.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Biovac Main Business Overview
13.19.5 Biovac Latest Developments
13.20 Atafen
13.20.1 Atafen Company Information
13.20.2 Atafen Veterinary Biological Vaccines Product Portfolios and Specifications
13.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Atafen Main Business Overview
13.20.5 Atafen Latest Developments
13.21 Dyntec
13.21.1 Dyntec Company Information
13.21.2 Dyntec Veterinary Biological Vaccines Product Portfolios and Specifications
13.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Dyntec Main Business Overview
13.21.5 Dyntec Latest Developments
13.22 Ringpu Biology
13.22.1 Ringpu Biology Company Information
13.22.2 Ringpu Biology Veterinary Biological Vaccines Product Portfolios and Specifications
13.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Ringpu Biology Main Business Overview
13.22.5 Ringpu Biology Latest Developments
13.23 Jinyu Bio-technology
13.23.1 Jinyu Bio-technology Company Information
13.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolios and Specifications
13.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Jinyu Bio-technology Main Business Overview
13.23.5 Jinyu Bio-technology Latest Developments
13.24 Jinhe Biotechnology
13.24.1 Jinhe Biotechnology Company Information
13.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolios and Specifications
13.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Jinhe Biotechnology Main Business Overview
13.24.5 Jinhe Biotechnology Latest Developments
13.25 China Animal Husbandry Industry
13.25.1 China Animal Husbandry Industry Company Information
13.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolios and Specifications
13.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 China Animal Husbandry Industry Main Business Overview
13.25.5 China Animal Husbandry Industry Latest Developments
13.26 Wuhan Keqian Biology
13.26.1 Wuhan Keqian Biology Company Information
13.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolios and Specifications
13.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.26.4 Wuhan Keqian Biology Main Business Overview
13.26.5 Wuhan Keqian Biology Latest Developments
13.27 Pulike Biological Engineering
13.27.1 Pulike Biological Engineering Company Information
13.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolios and Specifications
13.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.27.4 Pulike Biological Engineering Main Business Overview
13.27.5 Pulike Biological Engineering Latest Developments
13.28 Chengdu Kanghua Biological Products
13.28.1 Chengdu Kanghua Biological Products Company Information
13.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolios and Specifications
13.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.28.4 Chengdu Kanghua Biological Products Main Business Overview
13.28.5 Chengdu Kanghua Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Veterinary Biological Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Biological Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Others
Table 6. Global Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 7. Global Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Table 8. Global Veterinary Biological Vaccines Revenue byType (2020-2025) & ($ million)
Table 9. Global Veterinary Biological Vaccines Revenue Market Share byType (2020-2025)
Table 10. Global Veterinary Biological Vaccines Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Veterinary Biological Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Veterinary Biological Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Veterinary Biological Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Veterinary Biological Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Veterinary Biological Vaccines Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Veterinary Biological Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Veterinary Biological Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Veterinary Biological Vaccines Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution and Sales Area
Table 22. Players Veterinary Biological Vaccines Products Offered
Table 23. Veterinary Biological Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Veterinary Biological Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Veterinary Biological Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Veterinary Biological Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Veterinary Biological Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Veterinary Biological Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Veterinary Biological Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Veterinary Biological Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Veterinary Biological Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Veterinary Biological Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 38. Americas Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Veterinary Biological Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Veterinary Biological Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Veterinary Biological Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 43. APAC Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Veterinary Biological Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 47. Europe Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Veterinary Biological Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Veterinary Biological Vaccines
Table 53. Key Market Challenges & Risks of Veterinary Biological Vaccines
Table 54. Key IndustryTrends of Veterinary Biological Vaccines
Table 55. Veterinary Biological Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Veterinary Biological Vaccines Distributors List
Table 58. Veterinary Biological Vaccines Customer List
Table 59. Global Veterinary Biological Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Veterinary Biological Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Veterinary Biological Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Veterinary Biological Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Veterinary Biological Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Veterinary Biological Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Veterinary Biological Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Veterinary Biological Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Veterinary Biological Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Veterinary Biological Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Veterinary Biological Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Veterinary Biological Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Veterinary Biological Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Veterinary Biological Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Veterinary Biological Vaccines Product Portfolios and Specifications
Table 75. Merck Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Zoetis Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Veterinary Biological Vaccines Product Portfolios and Specifications
Table 80. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Ceva Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva Veterinary Biological Vaccines Product Portfolios and Specifications
Table 90. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. CAHIC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. CAHIC Veterinary Biological Vaccines Product Portfolios and Specifications
Table 95. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. CAHIC Main Business
Table 97. CAHIC Latest Developments
Table 98. HVRI Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. HVRI Veterinary Biological Vaccines Product Portfolios and Specifications
Table 100. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. HVRI Main Business
Table 102. HVRI Latest Developments
Table 103. Yebio Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Yebio Veterinary Biological Vaccines Product Portfolios and Specifications
Table 105. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Yebio Main Business
Table 107. Yebio Latest Developments
Table 108. DHN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. DHN Veterinary Biological Vaccines Product Portfolios and Specifications
Table 110. DHN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. DHN Main Business
Table 112. DHN Latest Developments
Table 113. WINSUN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. WINSUN Veterinary Biological Vaccines Product Portfolios and Specifications
Table 115. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. WINSUN Main Business
Table 117. WINSUN Latest Developments
Table 118. Elanco Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Elanco Veterinary Biological Vaccines Product Portfolios and Specifications
Table 120. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Elanco Main Business
Table 122. Elanco Latest Developments
Table 123. Virbac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Virbac Veterinary Biological Vaccines Product Portfolios and Specifications
Table 125. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Virbac Main Business
Table 127. Virbac Latest Developments
Table 128. CAVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. CAVAC Veterinary Biological Vaccines Product Portfolios and Specifications
Table 130. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. CAVAC Main Business
Table 132. CAVAC Latest Developments
Table 133. Kyoto Biken Laboratories Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolios and Specifications
Table 135. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Kyoto Biken Laboratories Main Business
Table 137. Kyoto Biken Laboratories Latest Developments
Table 138.FATRO Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139.FATRO Veterinary Biological Vaccines Product Portfolios and Specifications
Table 140.FATRO Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141.FATRO Main Business
Table 142.FATRO Latest Developments
Table 143. Vaksindo Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Vaksindo Veterinary Biological Vaccines Product Portfolios and Specifications
Table 145. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Vaksindo Main Business
Table 147. Vaksindo Latest Developments
Table 148. Bio-Labs Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Bio-Labs Veterinary Biological Vaccines Product Portfolios and Specifications
Table 150. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Bio-Labs Main Business
Table 152. Bio-Labs Latest Developments
Table 153. Avimex Animal Health Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Avimex Animal Health Veterinary Biological Vaccines Product Portfolios and Specifications
Table 155. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. Avimex Animal Health Main Business
Table 157. Avimex Animal Health Latest Developments
Table 158. MEVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. MEVAC Veterinary Biological Vaccines Product Portfolios and Specifications
Table 160. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. MEVAC Main Business
Table 162. MEVAC Latest Developments
Table 163. Biovac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Biovac Veterinary Biological Vaccines Product Portfolios and Specifications
Table 165. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. Biovac Main Business
Table 167. Biovac Latest Developments
Table 168. Atafen Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Atafen Veterinary Biological Vaccines Product Portfolios and Specifications
Table 170. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 171. Atafen Main Business
Table 172. Atafen Latest Developments
Table 173. Dyntec Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Dyntec Veterinary Biological Vaccines Product Portfolios and Specifications
Table 175. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 176. Dyntec Main Business
Table 177. Dyntec Latest Developments
Table 178. Ringpu Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. Ringpu Biology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 180. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 181. Ringpu Biology Main Business
Table 182. Ringpu Biology Latest Developments
Table 183. Jinyu Bio-technology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 185. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 186. Jinyu Bio-technology Main Business
Table 187. Jinyu Bio-technology Latest Developments
Table 188. Jinhe Biotechnology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 190. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 191. Jinhe Biotechnology Main Business
Table 192. Jinhe Biotechnology Latest Developments
Table 193. China Animal Husbandry Industry Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 194. China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolios and Specifications
Table 195. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 196. China Animal Husbandry Industry Main Business
Table 197. China Animal Husbandry Industry Latest Developments
Table 198. Wuhan Keqian Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 199. Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 200. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 201. Wuhan Keqian Biology Main Business
Table 202. Wuhan Keqian Biology Latest Developments
Table 203. Pulike Biological Engineering Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 204. Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolios and Specifications
Table 205. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 206. Pulike Biological Engineering Main Business
Table 207. Pulike Biological Engineering Latest Developments
Table 208. Chengdu Kanghua Biological Products Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 209. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolios and Specifications
Table 210. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 211. Chengdu Kanghua Biological Products Main Business
Table 212. Chengdu Kanghua Biological Products Latest Developments
LIST OFFIGURES
Figure 1. Picture of Veterinary Biological Vaccines
Figure 2. Veterinary Biological Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Biological Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Veterinary Biological Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Biological Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Biological Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Biological Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Others
Figure 14. Global Veterinary Biological Vaccines Sales Market Share byType in 2025
Figure 15. Global Veterinary Biological Vaccines Revenue Market Share byType (2020-2025)
Figure 16. Veterinary Biological Vaccines Consumed in Livestock
Figure 17. Global Veterinary Biological Vaccines Market: Livestock (2020-2025) & (K Units)
Figure 18. Veterinary Biological Vaccines Consumed in Swine
Figure 19. Global Veterinary Biological Vaccines Market: Swine (2020-2025) & (K Units)
Figure 20. Veterinary Biological Vaccines Consumed in Chicken
Figure 21. Global Veterinary Biological Vaccines Market: Chicken (2020-2025) & (K Units)
Figure 22. Veterinary Biological Vaccines Consumed in Others
Figure 23. Global Veterinary Biological Vaccines Market: Others (2020-2025) & (K Units)
Figure 24. Global Veterinary Biological Vaccines Sale Market Share by Application (2024)
Figure 25. Global Veterinary Biological Vaccines Revenue Market Share by Application in 2025
Figure 26. Veterinary Biological Vaccines Sales by Company in 2025 (K Units)
Figure 27. Global Veterinary Biological Vaccines Sales Market Share by Company in 2025
Figure 28. Veterinary Biological Vaccines Revenue by Company in 2025 ($ millions)
Figure 29. Global Veterinary Biological Vaccines Revenue Market Share by Company in 2025
Figure 30. Global Veterinary Biological Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 33. Americas Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 34. APAC Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 35. APAC Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Europe Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 37. Europe Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Americas Veterinary Biological Vaccines Sales Market Share by Country in 2025
Figure 41. Americas Veterinary Biological Vaccines Revenue Market Share by Country (2020-2025)
Figure 42. Americas Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 43. Americas Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 44. United States Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Veterinary Biological Vaccines Sales Market Share by Region in 2025
Figure 49. APAC Veterinary Biological Vaccines Revenue Market Share by Region (2020-2025)
Figure 50. APAC Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 51. APAC Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 52. China Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. India Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Veterinary Biological Vaccines Sales Market Share by Country in 2025
Figure 60. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2020-2025)
Figure 61. Europe Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 62. Europe Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 63. Germany Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64.France Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 71. Egypt Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines in 2025
Figure 77. Manufacturing Process Analysis of Veterinary Biological Vaccines
Figure 78. Industry Chain Structure of Veterinary Biological Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Veterinary Biological Vaccines Sales MarketForecast by Region (2026-2031)
Figure 81. Global Veterinary Biological Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Veterinary Biological Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Veterinary Biological Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Veterinary Biological Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Veterinary Biological Vaccines Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Biological Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Biological Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Biological Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Biological Vaccines Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Others
2.3 Veterinary Biological Vaccines Sales by Type
2.3.1 Global Veterinary Biological Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Biological Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Biological Vaccines Sale Price by Type (2020-2025)
2.4 Veterinary Biological Vaccines Segment by Application
2.4.1 Livestock
2.4.2 Swine
2.4.3 Chicken
2.4.4 Others
2.5 Veterinary Biological Vaccines Sales by Application
2.5.1 Global Veterinary Biological Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Biological Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Biological Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Biological Vaccines Breakdown Data by Company
3.1.1 Global Veterinary Biological Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Biological Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Biological Vaccines Revenue by Company (2020-2025)
3.2.2 Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Biological Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Biological Vaccines Product Location Distribution
3.4.2 Players Veterinary Biological Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY BIOLOGICAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Biological Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Biological Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Biological Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Biological Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Biological Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Biological Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Biological Vaccines Sales Growth
4.4 APAC Veterinary Biological Vaccines Sales Growth
4.5 Europe Veterinary Biological Vaccines Sales Growth
4.6 Middle East & Africa Veterinary Biological Vaccines Sales Growth
5 AMERICAS
5.1 Americas Veterinary Biological Vaccines Sales by Country
5.1.1 Americas Veterinary Biological Vaccines Sales by Country (2020-2025)
5.1.2 Americas Veterinary Biological Vaccines Revenue by Country (2020-2025)
5.2 Americas Veterinary Biological Vaccines Sales by Type (2020-2025)
5.3 Americas Veterinary Biological Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Biological Vaccines Sales by Region
6.1.1 APAC Veterinary Biological Vaccines Sales by Region (2020-2025)
6.1.2 APAC Veterinary Biological Vaccines Revenue by Region (2020-2025)
6.2 APAC Veterinary Biological Vaccines Sales by Type (2020-2025)
6.3 APAC Veterinary Biological Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Biological Vaccines by Country
7.1.1 Europe Veterinary Biological Vaccines Sales by Country (2020-2025)
7.1.2 Europe Veterinary Biological Vaccines Revenue by Country (2020-2025)
7.2 Europe Veterinary Biological Vaccines Sales by Type (2020-2025)
7.3 Europe Veterinary Biological Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Biological Vaccines by Country
8.1.1 Middle East & Africa Veterinary Biological Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Biological Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Biological Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines
10.3 Manufacturing Process Analysis of Veterinary Biological Vaccines
10.4 Industry Chain Structure of Veterinary Biological Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Biological Vaccines Distributors
11.3 Veterinary Biological Vaccines Customer
12 WORLD FORECAST REVIEW FOR VETERINARY BIOLOGICAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Veterinary Biological Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary Biological Vaccines Forecast by Region (2026-2031)
12.1.2 Global Veterinary Biological Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Biological Vaccines Forecast by Type (2026-2031)
12.7 Global Veterinary Biological Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Biological Vaccines Product Portfolios and Specifications
13.1.3 Merck Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Biological Vaccines Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Biological Vaccines Product Portfolios and Specifications
13.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Biological Vaccines Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Biological Vaccines Product Portfolios and Specifications
13.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Yebio
13.7.1 Yebio Company Information
13.7.2 Yebio Veterinary Biological Vaccines Product Portfolios and Specifications
13.7.3 Yebio Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Yebio Main Business Overview
13.7.5 Yebio Latest Developments
13.8 DHN
13.8.1 DHN Company Information
13.8.2 DHN Veterinary Biological Vaccines Product Portfolios and Specifications
13.8.3 DHN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 DHN Main Business Overview
13.8.5 DHN Latest Developments
13.9 WINSUN
13.9.1 WINSUN Company Information
13.9.2 WINSUN Veterinary Biological Vaccines Product Portfolios and Specifications
13.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 WINSUN Main Business Overview
13.9.5 WINSUN Latest Developments
13.10 Elanco
13.10.1 Elanco Company Information
13.10.2 Elanco Veterinary Biological Vaccines Product Portfolios and Specifications
13.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Elanco Main Business Overview
13.10.5 Elanco Latest Developments
13.11 Virbac
13.11.1 Virbac Company Information
13.11.2 Virbac Veterinary Biological Vaccines Product Portfolios and Specifications
13.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Virbac Main Business Overview
13.11.5 Virbac Latest Developments
13.12 CAVAC
13.12.1 CAVAC Company Information
13.12.2 CAVAC Veterinary Biological Vaccines Product Portfolios and Specifications
13.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CAVAC Main Business Overview
13.12.5 CAVAC Latest Developments
13.13 Kyoto Biken Laboratories
13.13.1 Kyoto Biken Laboratories Company Information
13.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolios and Specifications
13.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Kyoto Biken Laboratories Main Business Overview
13.13.5 Kyoto Biken Laboratories Latest Developments
13.14 FATRO
13.14.1 FATRO Company Information
13.14.2 FATRO Veterinary Biological Vaccines Product Portfolios and Specifications
13.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 FATRO Main Business Overview
13.14.5 FATRO Latest Developments
13.15 Vaksindo
13.15.1 Vaksindo Company Information
13.15.2 Vaksindo Veterinary Biological Vaccines Product Portfolios and Specifications
13.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Vaksindo Main Business Overview
13.15.5 Vaksindo Latest Developments
13.16 Bio-Labs
13.16.1 Bio-Labs Company Information
13.16.2 Bio-Labs Veterinary Biological Vaccines Product Portfolios and Specifications
13.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Bio-Labs Main Business Overview
13.16.5 Bio-Labs Latest Developments
13.17 Avimex Animal Health
13.17.1 Avimex Animal Health Company Information
13.17.2 Avimex Animal Health Veterinary Biological Vaccines Product Portfolios and Specifications
13.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Avimex Animal Health Main Business Overview
13.17.5 Avimex Animal Health Latest Developments
13.18 MEVAC
13.18.1 MEVAC Company Information
13.18.2 MEVAC Veterinary Biological Vaccines Product Portfolios and Specifications
13.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 MEVAC Main Business Overview
13.18.5 MEVAC Latest Developments
13.19 Biovac
13.19.1 Biovac Company Information
13.19.2 Biovac Veterinary Biological Vaccines Product Portfolios and Specifications
13.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Biovac Main Business Overview
13.19.5 Biovac Latest Developments
13.20 Atafen
13.20.1 Atafen Company Information
13.20.2 Atafen Veterinary Biological Vaccines Product Portfolios and Specifications
13.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Atafen Main Business Overview
13.20.5 Atafen Latest Developments
13.21 Dyntec
13.21.1 Dyntec Company Information
13.21.2 Dyntec Veterinary Biological Vaccines Product Portfolios and Specifications
13.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Dyntec Main Business Overview
13.21.5 Dyntec Latest Developments
13.22 Ringpu Biology
13.22.1 Ringpu Biology Company Information
13.22.2 Ringpu Biology Veterinary Biological Vaccines Product Portfolios and Specifications
13.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Ringpu Biology Main Business Overview
13.22.5 Ringpu Biology Latest Developments
13.23 Jinyu Bio-technology
13.23.1 Jinyu Bio-technology Company Information
13.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolios and Specifications
13.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Jinyu Bio-technology Main Business Overview
13.23.5 Jinyu Bio-technology Latest Developments
13.24 Jinhe Biotechnology
13.24.1 Jinhe Biotechnology Company Information
13.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolios and Specifications
13.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Jinhe Biotechnology Main Business Overview
13.24.5 Jinhe Biotechnology Latest Developments
13.25 China Animal Husbandry Industry
13.25.1 China Animal Husbandry Industry Company Information
13.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolios and Specifications
13.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 China Animal Husbandry Industry Main Business Overview
13.25.5 China Animal Husbandry Industry Latest Developments
13.26 Wuhan Keqian Biology
13.26.1 Wuhan Keqian Biology Company Information
13.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolios and Specifications
13.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.26.4 Wuhan Keqian Biology Main Business Overview
13.26.5 Wuhan Keqian Biology Latest Developments
13.27 Pulike Biological Engineering
13.27.1 Pulike Biological Engineering Company Information
13.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolios and Specifications
13.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.27.4 Pulike Biological Engineering Main Business Overview
13.27.5 Pulike Biological Engineering Latest Developments
13.28 Chengdu Kanghua Biological Products
13.28.1 Chengdu Kanghua Biological Products Company Information
13.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolios and Specifications
13.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.28.4 Chengdu Kanghua Biological Products Main Business Overview
13.28.5 Chengdu Kanghua Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Veterinary Biological Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Biological Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Others
Table 6. Global Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 7. Global Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Table 8. Global Veterinary Biological Vaccines Revenue byType (2020-2025) & ($ million)
Table 9. Global Veterinary Biological Vaccines Revenue Market Share byType (2020-2025)
Table 10. Global Veterinary Biological Vaccines Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Veterinary Biological Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Veterinary Biological Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Veterinary Biological Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Veterinary Biological Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Veterinary Biological Vaccines Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Veterinary Biological Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Veterinary Biological Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Veterinary Biological Vaccines Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution and Sales Area
Table 22. Players Veterinary Biological Vaccines Products Offered
Table 23. Veterinary Biological Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Veterinary Biological Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Veterinary Biological Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Veterinary Biological Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Veterinary Biological Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Veterinary Biological Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Veterinary Biological Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Veterinary Biological Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Veterinary Biological Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Veterinary Biological Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 38. Americas Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Veterinary Biological Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Veterinary Biological Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Veterinary Biological Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 43. APAC Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Veterinary Biological Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 47. Europe Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Veterinary Biological Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Veterinary Biological Vaccines Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Veterinary Biological Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Veterinary Biological Vaccines
Table 53. Key Market Challenges & Risks of Veterinary Biological Vaccines
Table 54. Key IndustryTrends of Veterinary Biological Vaccines
Table 55. Veterinary Biological Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Veterinary Biological Vaccines Distributors List
Table 58. Veterinary Biological Vaccines Customer List
Table 59. Global Veterinary Biological Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Veterinary Biological Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Veterinary Biological Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Veterinary Biological Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Veterinary Biological Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Veterinary Biological Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Veterinary Biological Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Veterinary Biological Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Veterinary Biological Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Veterinary Biological Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Veterinary Biological Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Veterinary Biological Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Veterinary Biological Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Veterinary Biological Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Veterinary Biological Vaccines Product Portfolios and Specifications
Table 75. Merck Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Zoetis Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Veterinary Biological Vaccines Product Portfolios and Specifications
Table 80. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Ceva Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva Veterinary Biological Vaccines Product Portfolios and Specifications
Table 90. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. CAHIC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. CAHIC Veterinary Biological Vaccines Product Portfolios and Specifications
Table 95. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. CAHIC Main Business
Table 97. CAHIC Latest Developments
Table 98. HVRI Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. HVRI Veterinary Biological Vaccines Product Portfolios and Specifications
Table 100. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. HVRI Main Business
Table 102. HVRI Latest Developments
Table 103. Yebio Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Yebio Veterinary Biological Vaccines Product Portfolios and Specifications
Table 105. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Yebio Main Business
Table 107. Yebio Latest Developments
Table 108. DHN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. DHN Veterinary Biological Vaccines Product Portfolios and Specifications
Table 110. DHN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. DHN Main Business
Table 112. DHN Latest Developments
Table 113. WINSUN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. WINSUN Veterinary Biological Vaccines Product Portfolios and Specifications
Table 115. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. WINSUN Main Business
Table 117. WINSUN Latest Developments
Table 118. Elanco Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Elanco Veterinary Biological Vaccines Product Portfolios and Specifications
Table 120. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Elanco Main Business
Table 122. Elanco Latest Developments
Table 123. Virbac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Virbac Veterinary Biological Vaccines Product Portfolios and Specifications
Table 125. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Virbac Main Business
Table 127. Virbac Latest Developments
Table 128. CAVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. CAVAC Veterinary Biological Vaccines Product Portfolios and Specifications
Table 130. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. CAVAC Main Business
Table 132. CAVAC Latest Developments
Table 133. Kyoto Biken Laboratories Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolios and Specifications
Table 135. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Kyoto Biken Laboratories Main Business
Table 137. Kyoto Biken Laboratories Latest Developments
Table 138.FATRO Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139.FATRO Veterinary Biological Vaccines Product Portfolios and Specifications
Table 140.FATRO Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141.FATRO Main Business
Table 142.FATRO Latest Developments
Table 143. Vaksindo Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Vaksindo Veterinary Biological Vaccines Product Portfolios and Specifications
Table 145. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Vaksindo Main Business
Table 147. Vaksindo Latest Developments
Table 148. Bio-Labs Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Bio-Labs Veterinary Biological Vaccines Product Portfolios and Specifications
Table 150. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Bio-Labs Main Business
Table 152. Bio-Labs Latest Developments
Table 153. Avimex Animal Health Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Avimex Animal Health Veterinary Biological Vaccines Product Portfolios and Specifications
Table 155. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. Avimex Animal Health Main Business
Table 157. Avimex Animal Health Latest Developments
Table 158. MEVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. MEVAC Veterinary Biological Vaccines Product Portfolios and Specifications
Table 160. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. MEVAC Main Business
Table 162. MEVAC Latest Developments
Table 163. Biovac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Biovac Veterinary Biological Vaccines Product Portfolios and Specifications
Table 165. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. Biovac Main Business
Table 167. Biovac Latest Developments
Table 168. Atafen Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Atafen Veterinary Biological Vaccines Product Portfolios and Specifications
Table 170. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 171. Atafen Main Business
Table 172. Atafen Latest Developments
Table 173. Dyntec Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Dyntec Veterinary Biological Vaccines Product Portfolios and Specifications
Table 175. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 176. Dyntec Main Business
Table 177. Dyntec Latest Developments
Table 178. Ringpu Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. Ringpu Biology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 180. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 181. Ringpu Biology Main Business
Table 182. Ringpu Biology Latest Developments
Table 183. Jinyu Bio-technology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 185. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 186. Jinyu Bio-technology Main Business
Table 187. Jinyu Bio-technology Latest Developments
Table 188. Jinhe Biotechnology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 190. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 191. Jinhe Biotechnology Main Business
Table 192. Jinhe Biotechnology Latest Developments
Table 193. China Animal Husbandry Industry Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 194. China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolios and Specifications
Table 195. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 196. China Animal Husbandry Industry Main Business
Table 197. China Animal Husbandry Industry Latest Developments
Table 198. Wuhan Keqian Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 199. Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolios and Specifications
Table 200. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 201. Wuhan Keqian Biology Main Business
Table 202. Wuhan Keqian Biology Latest Developments
Table 203. Pulike Biological Engineering Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 204. Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolios and Specifications
Table 205. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 206. Pulike Biological Engineering Main Business
Table 207. Pulike Biological Engineering Latest Developments
Table 208. Chengdu Kanghua Biological Products Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 209. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolios and Specifications
Table 210. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 211. Chengdu Kanghua Biological Products Main Business
Table 212. Chengdu Kanghua Biological Products Latest Developments
LIST OFFIGURES
Figure 1. Picture of Veterinary Biological Vaccines
Figure 2. Veterinary Biological Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Biological Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Veterinary Biological Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Biological Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Biological Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Biological Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Others
Figure 14. Global Veterinary Biological Vaccines Sales Market Share byType in 2025
Figure 15. Global Veterinary Biological Vaccines Revenue Market Share byType (2020-2025)
Figure 16. Veterinary Biological Vaccines Consumed in Livestock
Figure 17. Global Veterinary Biological Vaccines Market: Livestock (2020-2025) & (K Units)
Figure 18. Veterinary Biological Vaccines Consumed in Swine
Figure 19. Global Veterinary Biological Vaccines Market: Swine (2020-2025) & (K Units)
Figure 20. Veterinary Biological Vaccines Consumed in Chicken
Figure 21. Global Veterinary Biological Vaccines Market: Chicken (2020-2025) & (K Units)
Figure 22. Veterinary Biological Vaccines Consumed in Others
Figure 23. Global Veterinary Biological Vaccines Market: Others (2020-2025) & (K Units)
Figure 24. Global Veterinary Biological Vaccines Sale Market Share by Application (2024)
Figure 25. Global Veterinary Biological Vaccines Revenue Market Share by Application in 2025
Figure 26. Veterinary Biological Vaccines Sales by Company in 2025 (K Units)
Figure 27. Global Veterinary Biological Vaccines Sales Market Share by Company in 2025
Figure 28. Veterinary Biological Vaccines Revenue by Company in 2025 ($ millions)
Figure 29. Global Veterinary Biological Vaccines Revenue Market Share by Company in 2025
Figure 30. Global Veterinary Biological Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 33. Americas Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 34. APAC Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 35. APAC Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Europe Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 37. Europe Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Veterinary Biological Vaccines Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Veterinary Biological Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Americas Veterinary Biological Vaccines Sales Market Share by Country in 2025
Figure 41. Americas Veterinary Biological Vaccines Revenue Market Share by Country (2020-2025)
Figure 42. Americas Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 43. Americas Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 44. United States Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Veterinary Biological Vaccines Sales Market Share by Region in 2025
Figure 49. APAC Veterinary Biological Vaccines Revenue Market Share by Region (2020-2025)
Figure 50. APAC Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 51. APAC Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 52. China Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. India Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Veterinary Biological Vaccines Sales Market Share by Country in 2025
Figure 60. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2020-2025)
Figure 61. Europe Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 62. Europe Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 63. Germany Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64.France Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Veterinary Biological Vaccines Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
Figure 71. Egypt Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Veterinary Biological Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines in 2025
Figure 77. Manufacturing Process Analysis of Veterinary Biological Vaccines
Figure 78. Industry Chain Structure of Veterinary Biological Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Veterinary Biological Vaccines Sales MarketForecast by Region (2026-2031)
Figure 81. Global Veterinary Biological Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Veterinary Biological Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Veterinary Biological Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Veterinary Biological Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Veterinary Biological Vaccines Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Antiepileptic Drugs Market Growth 2024-2030
US$ 3,660.00
March 2024
111 pages
Global Medical Gauze Market Growth 2024-2030
US$ 3,660.00
November 2024
138 pages
Global Lid Plate Market Growth 2024-2030
US$ 3,660.00
September 2024
119 pages
Global Ischemic Stroke Diagnostic Equipment Market Growth 2024-2030
US$ 3,660.00
June 2024
119 pages
Global Biochemical Reagent Market Growth 2023-2029
US$ 3,660.00
March 2023
111 pages
